Overview

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia

Status:
Completed

Trial end date:
2020-04-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the pharmacokinetics of an oral omadacycline dosing regimen in the treatment of adults with CABP.

Phase:

Phase 1

Details

Lead Sponsor:

Paratek Pharmaceuticals Inc